Literature DB >> 20659624

Uric acid, CKD, and cardiovascular disease: confounders, culprits, and circles.

Navdeep Tangri, Daniel E Weiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20659624      PMCID： PMC4433758          DOI： 10.1053/j.ajkd.2010.06.004

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  20 in total

1.  Confounding and confounders.

Authors:  R McNamee
Journal:  Occup Environ Med       Date:  2003-03       Impact factor: 4.402

2.  Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.

Authors:  M Mazzali; J Hughes; Y G Kim; J A Jefferson; D H Kang; K L Gordon; H Y Lan; S Kivlighn; R J Johnson
Journal:  Hypertension       Date:  2001-11       Impact factor: 10.190

3.  Association of uric acid with change in kidney function in healthy normotensive individuals.

Authors:  Gianni Bellomo; Sandro Venanzi; Claudio Verdura; Paolo Saronio; Antonella Esposito; Mario Timio
Journal:  Am J Kidney Dis       Date:  2010-04-10       Impact factor: 8.860

4.  Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.

Authors:  B F Culleton; M G Larson; W B Kannel; D Levy
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

Review 5.  The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.

Authors:  Giuseppe Remuzzi; Norberto Perico; Manuel Macia; Piero Ruggenenti
Journal:  Kidney Int Suppl       Date:  2005-12       Impact factor: 10.545

6.  Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.

Authors:  Leo K Niskanen; David E Laaksonen; Kristiina Nyyssönen; Georg Alfthan; Hanna-Maaria Lakka; Timo A Lakka; Jukka T Salonen
Journal:  Arch Intern Med       Date:  2004-07-26

7.  Uric acid and incident kidney disease in the community.

Authors:  Daniel E Weiner; Hocine Tighiouart; Essam F Elsayed; John L Griffith; Deeb N Salem; Andrew S Levey
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

8.  Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk.

Authors:  Giuseppe Mercuro; Cristiana Vitale; Elena Cerquetani; Sandra Zoncu; Martino Deidda; Massimo Fini; Giuseppe M C Rosano
Journal:  Am J Cardiol       Date:  2004-10-01       Impact factor: 2.778

9.  Cardiovascular disease and subsequent kidney disease.

Authors:  Essam F Elsayed; Hocine Tighiouart; John Griffith; Tobias Kurth; Andrew S Levey; Deeb Salem; Mark J Sarnak; Daniel E Weiner
Journal:  Arch Intern Med       Date:  2007-06-11

10.  The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease.

Authors:  Khaled M Talaat; Amira R el-Sheikh
Journal:  Am J Nephrol       Date:  2007-07-04       Impact factor: 3.754
View more
  13 in total

Review 1.  Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.

Authors:  Richard J Johnson; George L Bakris; Claudio Borghi; Michel B Chonchol; David Feldman; Miguel A Lanaspa; Tony R Merriman; Orson W Moe; David B Mount; Laura Gabriella Sanchez Lozada; Eli Stahl; Daniel E Weiner; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2018-02-27       Impact factor: 8.860

Review 2.  Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?

Authors:  Ambreen Gul; Philip Zager
Journal:  Curr Diab Rep       Date:  2018-03-01       Impact factor: 4.810

3.  Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function.

Authors:  Kim Hughes; Tanya Flynn; Janak de Zoysa; Nicola Dalbeth; Tony R Merriman
Journal:  Kidney Int       Date:  2013-09-18       Impact factor: 10.612

4.  Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.

Authors:  Giacomo Zoppini; Giovanni Targher; Michel Chonchol; Vittorio Ortalda; Cataldo Abaterusso; Isabella Pichiri; Carlo Negri; Enzo Bonora
Journal:  Diabetes Care       Date:  2011-10-25       Impact factor: 19.112

5.  The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patients.

Authors:  Jie Dong; Qing-Feng Han; Tong-Ying Zhu; Ye-Ping Ren; Jiang-Hua Chen; Hui-Ping Zhao; Meng-Hua Chen; Rong Xu; Yue Wang; Chuan-Ming Hao; Rui Zhang; Xiao-Hui Zhang; Mei Wang; Na Tian; Hai-Yan Wang
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

6.  Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study.

Authors:  Johannes Nossent; Warren Raymond; Mark Divitini; Matthew Knuiman
Journal:  BMC Cardiovasc Disord       Date:  2016-12-15       Impact factor: 2.298

7.  A higher baseline plasma uric acid level is an independent predictor of arterial stiffness: A community-based prospective study.

Authors:  Xiao-Han Ding; Xiaona Wang; Ruihua Cao; Xu Yang; Wenkai Xiao; Yun Zhang; Yongyi Bai; Hongmei Wu; Ping Ye
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

8.  The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study.

Authors:  Francesco Locatelli; Goce Spasovski; Nada Dimkovic; Christoph Wanner; Frank Dellanna; Giuseppe Pontoriero
Journal:  Nephrol Dial Transplant       Date:  2013-12-02       Impact factor: 5.992

9.  Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study.

Authors:  V Cornejo Del Río; J Mostaza; C Lahoz; V Sánchez-Arroyo; C Sabín; S López; P Patrón; P Fernández-García; B Fernández-Puntero; D Vicent; L Montesano-Sánchez; F García-Iglesias; T González-Alegre; E Estirado; F Laguna; C de Burgos-Lunar; P Gómez-Campelo; J C Abanades-Herranz; J M de Miguel-Yanes; M A Salinero-Fort
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

10.  Assessment of the efficacy of hemodialysis on uric acid clearance in a sub-Saharan African population at the end stage kidney disease.

Authors:  Marie Doualla; Jan René Nkeck; Marie Patrice Halle; Félicité Kamdem; Aude Ingrid Agouak; Mickael Essouma; Yonathan Batchama Lobe; Gloria Ashuntantang
Journal:  BMC Nephrol       Date:  2020-08-31       Impact factor: 2.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.